april 22 semaglutide As of February 21, 2025, the FDA updated its drug shortage list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A GLP-1 drugs are the biggest

Ozempic side effects: What you should know

BNPL acceptance for tirzepatide breaks down into three categories: online telehealth platforms, in-person medical spas and clinics, and compounding pharmacies

A report with no lab name is a weak signal

Comparing Semaglutide and Tirzepatide While both semaglutide and tirzepatide are effective in managing obesity and type 2 diabetes, their mechanisms of action differ slightly: Semaglutide is a GLP-1 receptor agonist that primarily works by: - Slowing gastric emptying - Reducing appetite through brain signaling - Stimulating insulin release from the pancreas - Decreasing glucagon secretion Tirzepatide, on the other hand, is a dual GIP and GLP-1 receptor agonist, often referred to as a "twincretin"[8]

How much weight can you realistically lose on spironolactone